JERSEY CITY, N.J., March 29, 2017 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ:SCYX), a drug development company committed to the
development and commercialization of novel anti-infectives to address significant unmet therapeutic needs, today announced that the
Company will present at the 16th Annual Needham Healthcare Conference at The Westin New York Grand Central on Wednesday,
April 5, 2017 at 1:40 p.m. ET.
A live webcast will be available on the Investors section of the Company's website: www.scynexis.com. A replay of the presentation will be available approximately two hours after
the event and will be available for two weeks following the presentation.
About SCYNEXIS
SCYNEXIS is a drug development company committed to the development and commercialization of novel anti-infectives to address
significant unmet therapeutic needs. We are developing our lead product candidate, SCY-078, as an oral and IV drug for the
treatment of several fungal infections, including serious and life-threatening invasive fungal infections. For more information,
visit www.scynexis.com.
CONTACT: Media Relations Cammy Duong MacDougall Biomedical Communications Tel: 781-591-3443 cduong@macbiocom.com Investor Relations Susan Kim Argot Partners Tel: 212-203-4433 susan@argotpartners.com
